Skip to main content
ArticleOPEN ACCESS

Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy (CNS Drugs, (2019), 33, 3, (283-291), 10.1007/s40263-019-00607-5)

CNS Drugs
DOI: 10.1007/s40263-019-00653-z
2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The correct name of the co-author should be ‘‘Vajiheh Aghamollaii’’, and not ‘‘Vajihe Aghamollaii’’ as given in the original publication of the article.

Cite

CITATION STYLE

APA

Gharaylou, Z., Tafakhori, A., Agah, E., Aghamollaii, V., Kebriaeezadeh, A., & Hadjighassem, M. (2019, August 1). Correction to: A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy (CNS Drugs, (2019), 33, 3, (283-291), 10.1007/s40263-019-00607-5). CNS Drugs. Springer International Publishing. https://doi.org/10.1007/s40263-019-00653-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free